Noble BioVentures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Inactive
  • Investments
  • 13
  • Portfolio
  • 5
  • Exits
  • 5
Exits

Noble BioVentures General Information

Description

Noble BioVentures was a venture management group that used to leverages the infrastructure, technical capabilities and executive management talent pool of its commercial services affiliate Noble Life Sciences. The firm was focused on early-stage technology-oriented biomedical firms developing novel therapeutic molecules and treatments, diagnostic products or tools for biomedical research and development. It was founded in 2009 and was based in Gaithersburg, Maryland.

Contact Information

Year Founded
2009
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
  • Gaithersburg, MD
  • United States

Noble BioVentures Investments (13)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Iterion Therapeutics 18-Jun-2015 Early Stage VC 000 Biotechnology Clinical Trials - Phase 1 0000000 000000 00.0
000000000 17-Jul-2014 00000 00000 000 Biotechnology Clinical Trials - Phase 1 00000 000000000
0000000000 08-Apr-2014 0000 00000 00000 Drug Discovery Startup 00000 000000000
0000000 30-Sep-2012 00000 00000 0000 Diagnostic Equipment Generating Revenue
000000000 00000000 21-Sep-2012 00000 00000 00.000 Biotechnology Profitable
00000 0000 0000000 30-Mar-2012 0000 00000 00000 Biotechnology Generating Revenue
0000 000000000000 07-Feb-2006 00000 00000 000.00 Pharmaceuticals Out of Business
000000000 00000000 09-Sep-2005 00000 00000 000.00 Biotechnology Profitable
Predix Pharmaceuticals Holdings 25-Jan-2005 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
Aryx Therapeutics 02-Jun-2004 Later Stage VC 0000 Pharmaceuticals Out of Business
You’re viewing 10 of 13 investments. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Noble BioVentures Exits (5)

Company Name Exit Date Exit Type Exit Size
TransMedics 02-May-2019 IPO 0000
000000000 14-Feb-2017 0000000000
000000 00000000000 13-Nov-2014 000 000.00
Predix Pharmaceuticals Holdings 16-Aug-2006 Merger/Acquisition 0000
GeneOhm Sciences 14-Feb-2006 Merger/Acquisition 00000
To view Noble BioVentures’s complete exits history, request access »

Noble BioVentures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial